Armistice Capital’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,988,000
| Closed | -$18.8M | – | 266 |
|
|
2025
Q1 | $18.8M | Buy |
+2,988,000
| New | +$18.8M | 0.28% | 63 |
|
|
2022
Q4 | – | Sell |
-864,000
| Closed | -$1.33M | – | 235 |
|
|
2022
Q3 | $1.33M | Buy |
864,000
+448,000
| +108% | +$690K | 0.02% | 131 |
|
|
2022
Q2 | $1.17K | Buy |
+416,000
| New | +$1.17K | 0.02% | 123 |
|
|
2022
Q1 | – | Sell |
-1,512,344
| Closed | -$1.18M | – | 184 |
|
|
2021
Q4 | $1.18M | Buy |
+1,512,344
| New | +$1.18M | 0.02% | 125 |
|